We are live on ! Find out more
Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Portfolio holdings

AUM $59.8B
1-Year Est. Return 29.42%
This Fund
S&P 500
This Quarter Est. Return
+4.07%
1 Year Est. Return
+29.42%
3 Year Est. Return
+77.06%
5 Year Est. Return
+66.38%
10 Year Est. Return
+178.95%
AUM
$1.41B
AUM Growth
+$202M
Cap. Flow
+$117M
Cap. Flow %
8.3%
Top 10 Hldgs %
56.47%
Holding
179
New
43
Increased
60
Reduced
34
Closed
41

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$5.6M
2
XOM icon
ExxonMobil
XOM
+$5.03M
3
CRM icon
Salesforce
CRM
+$4.43M
4
GD icon
General Dynamics
GD
+$4.31M
5
PAYX icon
Paychex
PAYX
+$4.28M

Sector Composition

Rank Sector Weight
1 Technology 2.76%
2 Financials 2.05%
3 Healthcare 1.9%
4 Industrials 1.47%
5 Consumer Staples 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPQ icon
126
HP
HPQ
$24.6B
$501K 0.04%
+21,863
New +$465K
DCT
127
DELISTED
DCT Industrial Trust Inc.
DCT
$480K 0.03%
+8,500
New +$503K
BMY icon
128
Bristol-Myers Squibb
BMY
$132B
$458K 0.03%
+7,292
New +$456K
ROL icon
129
Rollins
ROL
$18.5B
$443K 0.03%
+20,954
New +$428K
MDU icon
130
MDU Resources
MDU
$4.17B
$435K 0.03%
+43,864
New +$449K
DOX icon
131
Amdocs
DOX
$5.87B
$429K 0.03%
+6,341
New +$412K
V icon
132
Visa
V
$673B
$415K 0.03%
+3,458
New +$382K
AR icon
133
Antero Resources
AR
$10.9B
$413K 0.03%
+20,799
New +$399K
ABBV icon
134
AbbVie
ABBV
$455B
$399K 0.03%
+3,978
New +$375K
BIO icon
135
Bio-Rad Laboratories Class A
BIO
$8.74B
$329K 0.02%
+1,324
New +$321K
SPY icon
136
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$294K 0.02%
+1,057
New +$275K
EEM icon
137
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$268K 0.02%
5,409
SCHB icon
138
Schwab US Broad Market ETF
SCHB
$43B
$216K 0.02%
+19,344
New +$203K
AMAT icon
139
Applied Materials
AMAT
$398B
-19,838
Closed -$1.04M
AMGN icon
140
Amgen
AMGN
$209B
-5,177
Closed -$962K
BA icon
141
Boeing
BA
$175B
-14,828
Closed -$3.83M
BAC icon
142
Bank of America
BAC
$433B
-38,888
Closed -$1.02M
BAX icon
143
Baxter International
BAX
$13.8B
-14,679
Closed -$923K
CHTR icon
144
Charter Communications
CHTR
$16.9B
-3,378
Closed -$1.24M
CNA icon
145
CNA Financial
CNA
$14.4B
-16,604
Closed -$838K
CNP icon
146
CenterPoint Energy
CNP
$27.8B
-30,627
Closed -$885K
CRM icon
147
Salesforce
CRM
$148B
-46,020
Closed -$4.43M
DLTR icon
148
Dollar Tree
DLTR
$24.7B
-31,792
Closed -$2.84M
EA icon
149
Electronic Arts
EA
$52.9B
-11,586
Closed -$1.39M
EBAY icon
150
eBay
EBAY
$50.4B
-25,196
Closed -$978K

Similar funds

Wealth Enhancement Advisory Services's Q4 2017 Portfolio in Review

As of Q4 2017, Wealth Enhancement Advisory Services held 179 positions worth $1.41B, up 17% from $1.21B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Wealth Enhancement Advisory Services deployed $117M of net new capital in Q4 2017, opening 43 new positions and adding to 60 existing holdings. Its largest new stake was SunTrust Banks, Inc.: 68,903 shares worth $4.75M.

By sector, the portfolio is most concentrated in Technology at 2.8% of assets, up from 2.6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Intuitive Surgical, an estimated $5.6M trimmed.

  • Wealth Enhancement Advisory Services's largest Q4 2017 buy was SunTrust Banks, Inc.: 68,903 shares worth $4.75M.
  • Wealth Enhancement Advisory Services added most to Schwab US Large-Cap Value ETF in Q4 2017, an estimated $13.7M increase.
  • Wealth Enhancement Advisory Services's biggest Q4 2017 reduction was Intuitive Surgical, cutting an estimated $5.6M.
  • Wealth Enhancement Advisory Services fully exited Salesforce in Q4 2017, selling an estimated $4.43M.
  • Wealth Enhancement Advisory Services's ten largest holdings make up 56% of its $1.41B portfolio in Q4 2017.
  • Wealth Enhancement Advisory Services opened 43 new positions and closed 41 in Q4 2017.
  • Wealth Enhancement Advisory Services's portfolio value rose 17% quarter-over-quarter to $1.41B.

Based on Wealth Enhancement Advisory Services's 13F filing for Q4 2017, filed 19 Jan 2018.